Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases. [PDF]
Huang H, Wei X.
europepmc +1 more source
Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy. [PDF]
Atanasiu D+3 more
europepmc +1 more source
Comparative Analysis of Bispecific Antibodies and CAR T-Cell Therapy in Follicular Lymphoma. [PDF]
Morabito F+7 more
europepmc +1 more source
Comparison of enriched charge variants from different anti-CD3 bispecific antibodies reveals differential susceptibility of each bispecific arm to post-translational modification. [PDF]
Nguyen JB+20 more
europepmc +1 more source
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A Review. [PDF]
Sassine J, Siegrist EA, Chemaly RF.
europepmc +1 more source
Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence. [PDF]
Hushmandi K+11 more
europepmc +1 more source
Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors. [PDF]
Gu Y, Zhao Q.
europepmc +1 more source
Targeting T cells with tetravalent bispecific antibodies for the treatment of graft-versus-host disease. [PDF]
Espinosa-Cotton M+4 more
europepmc +1 more source
Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication. [PDF]
Goldmacher VS, Gershteyn IM, Kovtun Y.
europepmc +1 more source